Oxford University Hospitals NHS Foundation Trust and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.
Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom.
Am J Ophthalmol. 2019 Jun;202:23-29. doi: 10.1016/j.ajo.2019.01.027. Epub 2019 Feb 4.
Mutations in the photoreceptor gene RP1 lead to recessive or dominantly inherited retinitis pigmentosa (RP). Since the dominantly inherited phenotype is generally milder than recessive cases, it raises the possibility that it could arise by haploinsufficiency; however, most mutations are in the terminal exon 4, which would be predicted to generate truncated proteins. We therefore assessed a cohort of RP patients with confirmed mutations in RP1 to examine the genetic basis of the exon 4 mutations.
Observational case series.
A retrospective review of 15 patients, aged between 36 and 84, with RP1 mutations in exon 4 confirmed by Sanger sequencing. All patients underwent full ophthalmic examination.
Two patients had homozygous mutations in RP1, p.(Glu1526*) and p.(Ser486fs), and presented with severe early-onset retinal degeneration. Their first-degree relatives were unaffected. Thirteen patients had dominantly inherited RP presenting in adult life with a rod-cone dystrophy phenotype. Four novel mutations were identified. All mutations were predicted to produce truncated RP1 protein of variable lengths, as follows: p.(Arg677*), p.(Gln679*), p.(Leu722*), p.(Ile725Argfs6), p.(Ser734)x2, p.(Leu762Tyrfs17)x2, p.(Leu866Lysfs7)x2, p.(Arg872Thrfs2)x2, and p.(Gln917).
The RP1 protein with a predicted length between 677 and 917 amino acids seems to have a dominant negative effect, whereas proteins shorter (486 amino acids) or longer than this (1526 amino acids) lead to a more severe phenotype, but only in homozygous individuals. Since mutations at various points along exon 4 have divergent consequences, genetic testing alone may be insufficient for counseling, but recessive inheritance should be considered likely in severe early-onset cases.
视蛋白基因 RP1 的突变导致隐性或显性遗传的色素性视网膜炎(RP)。由于显性遗传表型通常比隐性病例更为轻微,因此有可能是由于杂合子功能不全引起的;然而,大多数突变位于末端外显子 4 中,这将导致截短蛋白的产生。因此,我们评估了一组经证实存在 RP1 外显子 4 突变的 RP 患者,以检查外显子 4 突变的遗传基础。
观察性病例系列。
对 15 名年龄在 36 岁至 84 岁之间的患者进行回顾性分析,这些患者的 RP1 突变在外显子 4 中通过 Sanger 测序得到确认。所有患者均接受了全面的眼科检查。
两名患者为 RP1 纯合突变,p.(Glu1526*)和 p.(Ser486fs),表现为严重的早发性视网膜变性。他们的一级亲属未受影响。13 名患者为显性遗传性 RP,成年后出现视杆-视锥营养不良表型。发现了 4 种新的突变。所有突变均预测产生长短不一的截短 RP1 蛋白,如下所示:p.(Arg677*)、p.(Gln679*)、p.(Leu722*)、p.(Ile725Argfs6)、p.(Ser734)x2、p.(Leu762Tyrfs17)x2、p.(Leu866Lysfs7)x2、p.(Arg872Thrfs2)x2 和 p.(Gln917)。
RP1 蛋白的预测长度在 677 到 917 个氨基酸之间似乎具有显性负效应,而短于(486 个氨基酸)或长于(1526 个氨基酸)该长度的蛋白则导致更严重的表型,但仅在纯合子个体中。由于外显子 4 中不同点的突变具有不同的后果,因此仅凭基因检测可能不足以进行咨询,但应考虑严重早发性病例中隐性遗传的可能性。